More Questions?

Find the answers to your SenoBright questions and learn more about GE Healthcare's commitment to breast cancer awareness. Use this information to stay informed of breast cancer news, resources, and events.

Answers to Your SenoBright Questions

Here are some common questions women ask when they’re considering a SenoBright exam. If you still have your own questions about SenoBright, talk to your doctor.


Is a SenoBright exam typically reimbursed by Medicare and/or insurance providers?

SenoBright CESM may be covered by Medicare and selected insurance providers.

As payment amounts and coverage policies for specific procedures vary by location, please check with your insurance provider to confirm the exact terms of coverage for CESM.

Back to top

What is the radiation dose associated with SenoBright?

The CESM exam is very similar to a typical diagnostic mammogram. The main difference is that you will receive an IV injection of an iodine contrast agent just before the two sets of x-ray images are taken (one at high energy and another at low energy). While CESM offers an additional set of images for each breast, the total radiation dosage is only increased by about 20% compared to a standard mammogram depending on your breast size.

Read more about how CESM can provide you answers.

Back to top

Does CESM replace MRI?

FDA has cleared SenoBright CESM as an adjunct following mammography and ultrasound exams to help localize a known or suspected lesion.

Your doctor will use their best medical judgment to decide whether a CESM, a MRI, or both exams are necessary to evaluate whether or not you will need a biopsy.   

Back to top

How can I get a SenoBright exam?

A CESM exam can be requested by any physician, just like a diagnostic mammogram. Either radiologists or other referring physicians, such as gynecologists, general practitioners, oncologists and surgeons, can refer patients to a breast imaging center for the test.   

Back to top

What are the most frequent risks associated with iodine contrast injection?

SenoBright CESM requires the injection of an iodinated contrast agent which could cause mild to severe adverse reactions in some patients that could include, but are not limited to itching, hives, nasal congestion, and swelling about the eyes and face. In extreme cases more severe reactions can occur. Because some patients can have allergic reactions to iodine, be sure to inform your doctor or an imaging center staff member if you’ve ever had an allergic reaction to iodine contrast or shellfish.   

Back to top

Has Senobright been tested in clinical trials?

SenoBright CESM was launched three years ago following its initial clinical trial. CESM has proved its clinical value in different clinical trials and related publications are currently available on the internet.   

Back to top

Are there any physical limitations to using SenoBright (e.g. weight or claustrophobia)?

SenoBright uses standard mammogram equipment, so your exam experience will be very similar to what you’re used to.

Back to top

GE Healthcare's Commitment to Breast Cancer

Healthymagination

Healthymagination is GE’s strategy for taking on one of the toughest challenges: global health. Our mission: to improve the quality, access and affordability of care. Learn more >>



Breast Cancer Mosaic

Patient stories from the fight against breast cancer. Find inspiration and support here. Learn more >>



All Faces of Cancer

A survivor’s story about the importance of breast cancer screening. Learn more >>




GE Healthcare Newsroom

Follow the latest breast cancer news and information from GE Healthcare. Learn more >>




GE Healthcare on Pinterest

Explore inspiring images and stories from GE Heathcare and our community on Pinterest. Learn more >>



GE Healthcare's Get Fit Initiative

Simple, healthy habits can help you stay well and fight cancer. #GetFit is here to help. Learn more >>



Is My Cancer Different?

Is My Cancer Different?TM is an online movement created to educate individuals about the personalized treatments available for a range of cancers whose manifestations vary widely from person to person. Learn more >>